Stockscreener 앱 받기
0.518
4.06%
0.0176
전일 마감가:
$0.5004
열려 있는:
$0.5
하루 거래량:
685.99K
Relative Volume:
0.16
시가총액:
$34.13M
수익:
-
순이익/손실:
$-86.08M
주가수익비율:
-0.2401
EPS:
-2.1574
순현금흐름:
$-72.06M
1주 성능:
+19.70%
1개월 성능:
-71.07%
6개월 성능:
-40.69%
1년 성능:
-52.66%
1일 변동 폭
$0.50
$0.526
1주일 범위
$0.44
$0.5495
52주 변동 폭
$0.3234
$2.79
Io Biotech Inc Stock (IOBT) Company Profile
명칭
Io Biotech Inc
전화
(457) 070-2980
주소
OLE MAALOES VEH 3, COPENHAGEN
IOBT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
0.518 | 32.97M | 0 | -86.08M | -72.06M | -2.1574 |
|
VRTX
Vertex Pharmaceuticals Inc
|
415.33 | 107.98B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
455.77 | 59.07B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.00 | 59.76B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
800.82 | 49.19B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
337.13 | 38.56B | 4.56B | -176.77M | 225.30M | -1.7177 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-30 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-30 | 다운그레이드 | TD Cowen | Buy → Hold |
Io Biotech Inc 주식(IOBT)의 최신 뉴스
Multi asset correlation models including IO Biotech Inc.Market Performance Recap & Growth Oriented Trading Recommendations - newser.com
Layoff Tracker: Novo’s Cuts Leave Dozens of Manufacturing Workers Jobless - BioSpace
Tick level data insight on IO Biotech Inc. volatilityEarnings Beat & Risk Controlled Swing Trade Alerts - newser.com
How IO Biotech Inc. stock reacts to global recession fearsEntry Point & Safe Capital Growth Trade Ideas - newser.com
How sentiment analysis helps forecast IO Biotech Inc.Earnings Performance Report & Risk Managed Trade Strategies - newser.com
What does recent volatility data suggest for IO Biotech Inc.July 2025 Setups & Consistent Growth Equity Picks - newser.com
Analysts Set IO Biotech, Inc. (NASDAQ:IOBT) Price Target at $8.00 - Defense World
Applying chart zones and confluence areas to IO Biotech Inc.Portfolio Update Summary & Long-Term Safe Investment Plans - newser.com
IO Biotech (NASDAQ:IOBT) Downgraded to Equal Weight Rating by Morgan Stanley - Defense World
IO Biotech (IOBT) Downgraded to Hold by TD Cowen | IOBT Stock Ne - GuruFocus
IO Biotech Faces Setback as FDA Opposes Cylembio BLA Submission, Morgan Stanley Says - MarketScreener
IO Biotech Feels The Heat As US FDA Dashes Cylembio Filing Hopes - insights.citeline.com
IO Biotech (NASDAQ:IOBT) Receives "Hold" Rating from TD Cowen - MarketBeat
TD Cowen Maintains IO Biotech(IOBT.US) With Hold Rating - 富途牛牛
TD Cowen Downgrades IO Biotech to Hold From Buy - MarketScreener
FDA Recommends Against IO Biotech’s Cylembio Application - The Globe and Mail
Morgan Stanley Downgrades IO Biotech to Equalweight From Overweight, Cuts Price Target to $0.39 From $4 - MarketScreener
IO Biotech (NASDAQ:IOBT) Downgraded by HC Wainwright to “Neutral” - Defense World
IO Biotech stock rating downgraded to Hold by TD Cowen on FDA setback - Investing.com Canada
IO Biotech Stock Plunges After FDA Recommends Another Trial For Investigational Cancer Vaccine - NewsBreak: Local News & Alerts
IO Biotech stock downgraded to Neutral by H.C. Wainwright on trial delays - Investing.com Canada
IOBT Downgraded to Neutral by HC Wainwright & Co. | IOBT Stock News - GuruFocus
IO Biotech drops after FDA recommends another late-stage study for cancer vaccine - TradingView
IO Biotech stock plummets after FDA recommends against BLA submission By Investing.com - Investing.com Australia
IO Biotech stock plummets after FDA recommends against BLA submission - Investing.com India
IO Biotech Advised Against Filing Biologics License Application for Cylembio; Plans to Cut 50% of Workforce - MarketScreener
Nasdaq Jumps 150 Points; US Pending Home Sales Rise - Benzinga
FDA recommends against IO Biotech’s BLA for melanoma vaccine By Investing.com - Investing.com Canada
Io Biotech Announces Restructuring Plan, Plans Global Workforce Reduction of ~50% with One-Time Charges of $1?1.5 Million - MarketScreener
IO Biotech provides update following pre-BLA meeting with FDA - MarketScreener
Io Biotech Inc (IOBT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.89%
1.04%
자본화:
|
볼륨(24시간):